BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22270997)

  • 21. Surgical completeness of robotic thyroidectomy: a prospective comparison with conventional open thyroidectomy in papillary thyroid carcinoma patients.
    Lee S; Lee CR; Lee SC; Park S; Kim HY; Son H; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS; Cho A
    Surg Endosc; 2014 Apr; 28(4):1068-75. PubMed ID: 24221277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
    Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
    Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reoperative central lymph node dissection for incidental papillary thyroid cancer can be performed safely: A retrospective review.
    Hall CM; LaSeur DC; Snyder SK; Lairmore TC
    Int J Surg; 2018 Aug; 56():102-107. PubMed ID: 29920338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases.
    Sabra MM; Grewal RK; Ghossein RA; Tuttle RM
    Thyroid; 2014 Jul; 24(7):1088-95. PubMed ID: 24559250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
    So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
    Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer.
    Wang TS; Evans DB; Fareau GG; Carroll T; Yen TW
    Ann Surg Oncol; 2012 Dec; 19(13):4217-22. PubMed ID: 23010732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.
    Lang BH; Wong KP; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Jan; 19(1):60-7. PubMed ID: 21681379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer.
    Low TH; Delbridge L; Sidhu S; Learoyd D; Robinson B; Roach P; Sywak M
    Ann Surg Oncol; 2008 Oct; 15(10):2827-32. PubMed ID: 18636294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
    Hartl D; Godbert Y; Carrat X; Bardet S; Lasne-Cardon A; Vera P; Ilies E; Zerdoud S; Sarini J; Zalzali M; La Manna L; Schneegans O; Kelly A; Kauffmann P; Rodien P; Brunaud L; Grunenwald S; Housseau E; Laghouati S; Bouvet N; Lecerf E; Hadoux J; Lamartina L; Schlumberger M; Borget I
    Trials; 2023 Apr; 24(1):298. PubMed ID: 37118818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy.
    Lang BH; Ng SH; Lau LL; Cowling BJ; Wong KP; Wan KY
    Thyroid; 2013 Sep; 23(9):1087-98. PubMed ID: 23402640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: A case report and literature review.
    Yoo RE; Kim JH; Paeng JC; Park YJ
    Medicine (Baltimore); 2018 Mar; 97(9):e0003. PubMed ID: 29489641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human thyrotropin-stimulated thyroglobulin level at the time of radioactive iodine ablation is an independent prognostic marker of differentiated thyroid carcinoma in the setting of prophylactic central neck dissection.
    Moon JH; Choi JY; Jeong WJ; Ahn SH; Lee WW; Kim KM; Choi SH; Lim S; Park YJ; Yi KH; Park do J; Jang HC
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):459-65. PubMed ID: 26833982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of intraoperative determination of central node metastasis by the surgeon in papillary thyroid carcinoma.
    Ji YB; Lee DW; Song CM; Kim KR; Park CW; Tae K
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):542-7. PubMed ID: 24429357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prospective analysis of the risk factors and clinical indications of dissection of lymph node posterior to right recurrent laryngeal nerve in 283 cases of papillary thyroid carcinoma].
    Zhang P; Zhang B; Bu J; Liu Y; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):109-14. PubMed ID: 24796458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practice patterns among thyroid cancer surgeons: implications of performing a prophylactic central neck dissection.
    Deutschmann MW; Chin-Lenn L; Nakoneshny SC; Dort JC; Pasieka JL; Chandarana SP
    J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):55. PubMed ID: 27793192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer.
    de Meer SG; Dauwan M; de Keizer B; Valk GD; Borel Rinkes IH; Vriens MR
    World J Surg; 2012 Jun; 36(6):1262-7. PubMed ID: 22270993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
    Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
    World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.